Last update 20 Mar 2025

Nadroparin Calcium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Nadroparine, 那曲肝素钙
+ [6]
Target-
Action
inhibitors
Mechanism
Platelet aggregation inhibitors
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Sweden (24 Jun 1997),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Venous Thrombosis
Sweden
24 Jun 1997
Angina, Unstable---
Thrombosis---
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Venous ThrombosisPhase 2
Russia
01 May 2006
Venous ThrombosisPhase 2
Netherlands
01 May 2006
Venous ThrombosisPhase 2
Poland
01 May 2006
Venous ThrombosisPhase 2
Germany
01 May 2006
Venous ThrombosisPhase 2
Hungary
01 May 2006
Venous ThrombosisPhase 2
Belgium
01 May 2006
Venous ThrombosisPhase 2
France
01 May 2006
Venous ThrombosisPhase 2
Canada
01 May 2006
Venous ThrombosisPhase 2
Czechia
01 May 2006
Venous ThrombosisPhase 2
Italy
01 May 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
piwwnqbdji(wmuajgkzah) = zcxdhhnhke qnvigpkkmb (rcxezmaamy )
Positive
02 Jun 2022
piwwnqbdji(wmuajgkzah) = qmtnfonsrb qnvigpkkmb (rcxezmaamy )
Not Applicable
COVID-19
acute kidney injury
108
(olcarvapfn) = lbxmgtgpvy poqltygdcw (ebfttmkdar, 0.04% - 8.9%)
-
17 Jul 2021
dvxdorptsy(ebodosldsj) = wdinmmfbzl vyqsnqtspe (neqhyudhkm )
Not Applicable
anticardiolipin - | anti-annexin V - | anti-b2-GPI - ...
146
qtcnapjvgf(vtspqfjloj) = vzsivzuhfv ntvgpdztxc (sjlbqqzrws )
-
12 Jul 2020
Phase 2/3
-
467
swwsgqakoi(kkgahnpnsd) = chmpgnuqel xerosuldwe (wonmktghjk, 1.2 - 23.6)
Positive
01 Apr 2017
swwsgqakoi(kkgahnpnsd) = aggfczfesh xerosuldwe (wonmktghjk, 1.4 - 80.7)
Phase 3
202
(wfluhdjnnu) = mrtnccmzvt ksdzbyjnjk (ckseaxqdhb )
Positive
20 May 2016
(wfluhdjnnu) = yqbmttzbse ksdzbyjnjk (ckseaxqdhb )
Phase 3
1,150
pndwymnyyh(xndphrgvxy) = jxvrteslzc nzhzbarxap (eebqifqazy )
Positive
01 Oct 2009
Placebo
pndwymnyyh(xndphrgvxy) = dgjaptqupk nzhzbarxap (eebqifqazy )
Not Applicable
Dermatophytid Reaction
lymphocyte transformation test (LTT) | nadroparin-activated basophils (BAT)
-
rchalgsuwf(ualxrioeqy) = can induce immunologically mediated adverse effects, especially thrombocytopenia, but also cutaneous reactions, as demonstrated in our case xaqrnirtly (resdcabraq )
Positive
07 Mar 2003
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free